Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...

Randomized Experiments

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...

Parametric Survival Analysis: Weibull and Exponential Methods

Parametric Survival Analysis: Weibull and Exponential Methods

Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for k_a Estimation

This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Luminescent Polymorphic Co-crystals: A Promising Way to the Diversity of Molecular Assembly, Fluorescence Polarization, and Optical Waveguide.

ACS applied materials & interfaces·2020

Same author

Hyaluronic acid targeted and pH-responsive nanocarriers based on hollow mesoporous silica nanoparticles for chemo-photodynamic combination therapy.

Colloids and surfaces. B, Biointerfaces·2020

Same author

Tumor phase recognition using cone-beam computed tomography projections and external surrogate information.

Medical physics·2020

Same author

Realization of a time-correlated photon counting technique for fluorescence analysis.

Biomedical optics express·2020

Same author

Ultrasonographic Diagnosis of Lipomatosis of Nerve: A Review of Ultrasonographic Finding for 8 Cases.

World neurosurgery·2020

Same author

Is dietary fat associated with the risk of age-related macular degeneration? Protocol for a systematic review and meta-analysis.

Medicine·2020

Search research articles

Related Experiment Video

Updated: May 21, 2026

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on: May 13, 2022

Efficient Bayesian joint models for group randomized trials with multiple observation times and multiple outcomes.

Xinyi Xu¹, Michael L Pennell, Bo Lu

¹Department of Statistics, College of Math and Physical Sciences, The Ohio State University, Columbus, OH, USA.

Statistics in Medicine

|June 27, 2012

Summary

This study introduces a Bayesian approach for group randomized trials, improving the analysis of multiple outcomes over time. The method enhances estimation efficiency for treatment effects and correlations in complex study designs.

More Related Videos

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

Related Experiment Videos

Last Updated: May 21, 2026

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on: May 13, 2022

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

Area of Science:

Biostatistics
Clinical Trials Methodology
Statistical Modeling

Background:

Group randomized trials (GRTs) often involve multiple outcomes and repeated measurements.
Accurate statistical modeling is crucial for analyzing complex data structures in GRTs.
Existing methods may not fully account for the correlations inherent in longitudinal, multi-outcome data.

Purpose of the Study:

To propose a novel Bayesian method for analyzing group randomized trials.
To jointly model multiple, diverse outcomes observed at multiple time points.
To develop innovative priors for variance components to improve inference on correlations.

Main Methods:

Latent multivariate normal linear regression for joint modeling of outcomes.
Accounting for intraclass correlation, between-outcome correlation, and over-time correlation.
Development of novel priors for variance components enabling direct correlation inference.

Main Results:

The proposed Bayesian method improves estimation efficiency for intraclass correlations and treatment effects.
Simulations demonstrate superior performance compared to single-outcome models and models with diffuse priors.
The methodology is validated using body composition data from a real-world trial.

Conclusions:

The Bayesian approach provides a robust framework for complex group randomized trials.
The method enhances the precision of estimates for treatment effects and key correlation parameters.
This approach offers advantages for analyzing longitudinal, multi-outcome data in intervention studies.